ROLE FOR HERPESVIRUS SAIMIRI ORF14 IN TRANSFORMATION & PERSISTENT INFECTION
疱疹病毒 SAIMIRI ORF14 在转化中的作用
基本信息
- 批准号:6453737
- 负责人:
- 金额:$ 11.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-05-01 至 2002-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The product of open reading frame 14 (orft4) of herpesvirus
saimiri (HVS) exhibits significant homology with mouse mammary tumor
virus superantigen orfl4 encodes a 50-kDa secreted glycoprotein, as
shown previously (Z Yao, E Maraskovsky, M K Spriggs, J I Cohen, R J
Armitage, and M R Alderson, J Immunol 156:3260-3266, 1996) orfl4
expressed from recombinant baculovirus powerfully induces
proliferation of CD4-positive cells originating from several different
species To study the role of orfl4 in transformation, a mutant form of
HVS (HVS orfl4) was constructed with a deletion in the orfl4 gene The
transforming potential of HVS orfl4 was tested in cell culture and in
common marmosets Parental HVS subgroup C strain 488 immortalized
common marmoset T lymphocytes in vitro to interleukin-2-independent
growth, while the HVS orft4 mutant did not produce such a growth
transformation In addition, HVS orfl4 was nononcogenic in common
marmosets In contrast to oth er nononcogenic HVS mutant viruses which
were repeatedly isolated from peripheral blood mononuclear cells of
infected marmosets for more than 5 months, HVS orfl4 did not persist
at a high level in vivo These results demonstrate that orfl4 of HVS is
not required for replication but is required for transformation and
for high-level persistence in vivo PUBLICATIONS Duboise, SM, Guo, J,
Czajak, S, Lee, H, Veazey, Desrosiers, RC and Jung, JU A role for
herpesvirus saimiri orf14 in transformation and persistent infection J
Virol 1998; 72:6770-6776
疱疹病毒开放阅读框14(orft 4)产物
saimiri(HVS)与小鼠乳腺肿瘤具有显著的同源性
病毒超抗原orfl 4编码50-kDa分泌糖蛋白,如
如前所述(Z Yao,E Maraskovsky,M K Spriggs,J I Cohen,R J
Armitage和MR Alderson,J Immunol 156:3260-3266,1996)或fl 4
从重组杆状病毒中表达,
来自几种不同来源的CD 4阳性细胞的增殖
为了研究orf 14在转化中的作用,
构建了在orfl 4基因中缺失的HVS(HVS orfl 4)。
在细胞培养物中测试了HVS orf 14的转化潜力,
普通绒猴亲本HVS C亚群488株永生化
体外普通绒猴T淋巴细胞对白细胞介素-2的非依赖性
生长,而HVS orft 4突变体没有产生这样的生长
此外,HVS orf 14通常是非致癌的。
与其他非致癌性HVS突变病毒相反,
反复分离外周血单核细胞,
感染绒猴超过5个月,HVS或fl 4没有持续存在
这些结果表明,HVS的orf 14是
复制不需要,但转换需要,
对于体内高水平的持久性出版物Duboise,SM,Guo,J,
Czajak,S,Lee,H,Veazey,Desrosiers,RC和Jung,JU
松鼠猴疱疹病毒orf 14转化与持续感染J
病毒学1998; 72:6770-6776
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Samuel Monroe DUBOISE其他文献
Samuel Monroe DUBOISE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Samuel Monroe DUBOISE', 18)}}的其他基金
Micro-and Nano-space Explorations of Health and Disease
健康与疾病的微纳空间探索
- 批准号:
7902315 - 财政年份:2009
- 资助金额:
$ 11.11万 - 项目类别:
Micro-and Nano-space Explorations of Health and Disease
健康与疾病的微纳空间探索
- 批准号:
8019562 - 财政年份:2008
- 资助金额:
$ 11.11万 - 项目类别:
Micro-and Nano-space Explorations of Health and Disease
健康与疾病的微纳空间探索
- 批准号:
7326207 - 财政年份:2008
- 资助金额:
$ 11.11万 - 项目类别:
Micro-and Nano-space Explorations of Health and Disease
健康与疾病的微纳空间探索
- 批准号:
8333622 - 财政年份:2008
- 资助金额:
$ 11.11万 - 项目类别:
Micro-and Nano-space Explorations of Health and Disease
健康与疾病的微纳空间探索
- 批准号:
8228155 - 财政年份:2008
- 资助金额:
$ 11.11万 - 项目类别:
Micro-and Nano-space Explorations of Health and Disease
健康与疾病的微纳空间探索
- 批准号:
7557887 - 财政年份:2008
- 资助金额:
$ 11.11万 - 项目类别:
Micro-and Nano-space Explorations of Health and Disease
健康与疾病的微纳空间探索
- 批准号:
7761692 - 财政年份:2008
- 资助金额:
$ 11.11万 - 项目类别:
MUTATATED LCK BINDING MOTIF FOR LYMPHOID CELL ACTIVATION BY HERPESVIRUS SAIMIRI
疱疹病毒 SAIMIRI 激活淋巴细胞的突变 LCK 结合基序
- 批准号:
6591295 - 财政年份:2002
- 资助金额:
$ 11.11万 - 项目类别:
ROLE FOR HERPESVIRUS SAIMIRI ORF14 IN TRANSFORMATION & PERSISTENT INFECTION
疱疹病毒 SAIMIRI ORF14 在转化中的作用
- 批准号:
6591291 - 财政年份:2002
- 资助金额:
$ 11.11万 - 项目类别:
STP & TIP ARE ESSENTIAL FOR HERPESVIRUS SAIMIRI ONCOGENICITY
直通车
- 批准号:
6591296 - 财政年份:2002
- 资助金额:
$ 11.11万 - 项目类别:
相似海外基金
Develop a programme to support the prevention of Non-Communicable Diseases (NCDs) in the Republic of Kenya.
制定一项计划,支持肯尼亚共和国预防非传染性疾病 (NCD)。
- 批准号:
23K09892 - 财政年份:2023
- 资助金额:
$ 11.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Research Training in Global Non-Communicable Diseases
全球非传染性疾病研究培训
- 批准号:
10554719 - 财政年份:2023
- 资助金额:
$ 11.11万 - 项目类别:
Usefulness of metabolite biomarker as a common pathway for the prevention of non-communicable diseases and frailty
代谢生物标志物作为预防非传染性疾病和虚弱的常见途径的有用性
- 批准号:
23H00452 - 财政年份:2023
- 资助金额:
$ 11.11万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Strengthening Research Capacity in Innovative Global Health Technologies for Non-Communicable Diseases in Uganda
加强乌干达非传染性疾病创新全球卫生技术的研究能力
- 批准号:
10469877 - 财政年份:2022
- 资助金额:
$ 11.11万 - 项目类别:
Occupational disparities in survival from cancer and non-communicable diseases
癌症和非传染性疾病生存率的职业差异
- 批准号:
22K17401 - 财政年份:2022
- 资助金额:
$ 11.11万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Building capacity for Implementation Science research in Non-Communicable Diseases (BImS-NCDs)
非传染性疾病(BImS-NCD)实施科学研究的能力建设
- 批准号:
10594552 - 财政年份:2022
- 资助金额:
$ 11.11万 - 项目类别:
Building capacity for Implementation Science research in Non-Communicable Diseases (BImS-NCDs)
非传染性疾病(BImS-NCD)实施科学研究的能力建设
- 批准号:
10469788 - 财政年份:2022
- 资助金额:
$ 11.11万 - 项目类别:
United States-Zambia Addressing Risk Factors for Non-Communicable Diseases (US-Zambia Risk NCD)
美国-赞比亚解决非传染性疾病的风险因素(美国-赞比亚风险非传染性疾病)
- 批准号:
10462351 - 财政年份:2022
- 资助金额:
$ 11.11万 - 项目类别:
Development of a comprehensive self-care system utilizing big data/AI to cure non-communicable diseases and validation of its effectiveness
开发利用大数据/人工智能治疗非传染性疾病的综合自我护理系统并验证其有效性
- 批准号:
22H03529 - 财政年份:2022
- 资助金额:
$ 11.11万 - 项目类别:
Grant-in-Aid for Scientific Research (B)